Safety analysis of taking cabergoline

Cabergoline, as a long-acting ergot base derivative dopamine receptor agonist, has been widely used abroad to treat prolactin-type pituitary tumors and other diseases.

Cabergoline is highly effective in reducing prolactin levels, but its side effects should not be ignored. Common side effects include head discomfort such as dizziness and headache, which may be related to a drop in blood pressure caused by the drug. In addition, gastrointestinal reactions are also common, such as nausea and vomiting, especially when taken on an empty stomach. Therefore, patients are advised to take it after meals to relieve these discomforts.

In addition to the common side effects mentioned above, cabergoline may also cause more serious neurological discomfort reactions, such as nasal congestion, hallucinations, and mental confusion. Although these reactions are rare, if they occur, you should seek medical attention immediately and adjust your treatment plan.

It is worth noting that cabergoline has not yet been approved for marketing in China, which means that its use in China lacks sufficient clinical evidence to support it. Therefore, when patients choose to use cabergoline, they should fully understand its possible risks and take it under the guidance of a doctor.

In addition, the interaction of cabergoline with other drugs is a matter of concern. For example, dopamine antagonists such as metoclopramide or phenothiazines may reduce the effectiveness of cabergoline and therefore concomitant use should be avoided. At the same time, you should avoid drinking alcohol while taking the medication because ethanol may increase the body's sensitivity to the medication, thereby increasing the risk of side effects.

For patients who need to take cabergoline long-term, regular follow-up visits and monitoring of drug effects are crucial. Doctors will adjust the medication plan according to the patient's specific conditions to ensure the effectiveness and safety of the drug.